Self-reported psychopathological symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation
- 14 January 2004
- journal article
- research article
- Published by Springer Nature in Psychopharmacology
- Vol. 173 (3-4) , 398-404
- https://doi.org/10.1007/s00213-003-1719-0
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective studyBMJ, 2002
- Personality dimensions and psychopathological profiles of Ecstasy usersHuman Psychopharmacology: Clinical and Experimental, 2001
- Psychological profile of abstinent recreational Ecstasy (MDMA) users and significance of concomitant cannabis useHuman Psychopharmacology: Clinical and Experimental, 2001
- A review of the role of serotonin receptors in psychiatric disordersHuman Psychopharmacology: Clinical and Experimental, 2000
- Psychobiological problems in heavy 'ecstasy' (MDMA) polydrug usersDrug and Alcohol Dependence, 2000
- Recreational Use of “Ecstasy” (MDMA) Is Associated with Elevated ImpulsivityNeuropsychopharmacology, 1998
- Is the Use of Ecstasy and Hallucinogens Increasing?European Addiction Research, 1998
- Diversity of Psychopathology Associated with use of 3,4-Methylenedioxymethamphetamine (‘Ecstasy’)The British Journal of Psychiatry, 1994
- Self-Reported Drug Use Data: What Do They Reveal?The American Journal of Drug and Alcohol Abuse, 1993
- Psychiatric illness associated with "ecstasy"The Lancet, 1991